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Figure 2. Effect of intravenous verapamil (10 mg) on the junc-
tional rhythm. From top to bottom: there are no changes in the
junctional cycle length after verapamil. HRA = high right atrial
electrogram.
junctional rhythm rate. In a more recent clinical study, Hariman
et al. (3), by analyzing the response of junctional rhythm to over-
drive suppression, suggested that in some patients the location of
junctional rhythms may be indeed the N region of the atrioven-
tricular (AV) node; unfortunately, the responseof junctional rhythm
to verapamil to "confirm" the node location of the pacemaker
was not tested. In contrast, Schwartz et al. (2) recently reported
that, whatever the origin of the junctional rhythms, intravenous
verapamil enhances junctional automaticity in humans.
We report a case of a stable junctional rhythm at a rate of
80/min in a patient, a 58 year old woman, with sick sinus syn-
drome. Electrophysiologic study showed that the postpacing pauses
were more markedly prolonged after atrial pacing than after His
bundle pacing, even in the presence of 2: 1 AV node block, sug-
gesting that the junctional pacemaker was located cranial to the
His bundle; in fact, the His bundle was driven at a rate slower
than the spontaneous junctional rate during 2: 1 block (75/min)
(Fig. 1); thus, a pacemaker located below the AV node may not
have been suppressed. Intravenous verapamil (10 mg), in the ab-
sence of changes in systemic blood pressure, induced no change
in either the junctional rhythm rate (Fig. 2) or the postpacing
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Figure 1. Effect of overdrive suppression after atrial (AP) and
His bundle (HBP) pacing. From top to bottom: atrial and His
bundle pacing (cycle length [CLl 600 ms) for 1 minute were
followed by prolongation of junctional cycle length from 850 to
1,160 ms and from 850 to 960 ms, respectively (top two panels).
Atrial pacing at a cycle length of 400 ms results in 2: I AV node
block and in a prolongation of junctional cycle length from 850
to 1,200 ms (third panel from top); His bundle pacing at the
same cycle length (400 ms) results in 1: I conduction but in a
prolongation of junctional cycle length from 850 to 960 ms (bot-
tom panel). Time lines are at 1 second intervals and the paper
speed is 25 mmls. H = His bundle deflection; HBE = His bundle
electrogram; S = pacing spike.
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Recently, Hariman and Chen (I) and Schwartz et al. (2) reported
contrasting results on the effect of verapamil on junctional rhythms.
In particular, Hariman and Chen (1) postulated that the location
of the pacemaker in dogs with junctional rhythm induced by sinus
node ablation is the N region of the node. This assumption was
mainly suggested by the suppressive effect of verapamil on the
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values may overlap, individual data showing the change in aT-eT,
or ~ aT-eT, with exercise may quite possibly be a much improved
marker, and it would be useful for the authors to perform this
analysis.
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pauses, indicating the inability of diagnostic use of verapamil to
identify the site of the junctional rhythm.
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